PHARMExcel reports data for rare disease trials across 5 technologies
PHARMExcel reports on latest data for rare disease trials from 5 leading technologies.
Engaging patient and advocates in rare disease clinical trials
Ways to engage patients and advocates in rare disease clinical trials.
PHARMExcel at 15: Looking Forward
Yvanne Enever, PHARMExcel CEO reflects on 15 years’ CRO success and what lies ahead for PHARMExcel, its clients and partners.
PHARMExcel celebrates 15 years’ CRO impact in clinical trials for NHS, investigator and biotech research
Celebrating 15 years of delivering quality-driven clinical trials in the academic and commercial sector.
PHARMExcel awarded for impactful CRO services in ophthalmology clinical trials
High praise for the PHARMExcel team from the judges at the OBN Awards for exceptional services.
Why choose an ISO 9001-compliant CRO?
Is your CRO certified to ISO 9001 standards? Discover why this matters.
Your research, our priority: PHARMExcel’s commitment to delivering quality every time
Hear how PHARMExcel strikes the right balance between quality and speed for its clinical trial delivery
The challenges of financial forecasting in a growing CRO
PHARMExcel’s newest paper in Frontline Gastroenterology is now available
We’re thrilled to announce our newest paper in Frontline Gastroenterology is now published online.